肾脏疾病女性的性激素
综述探讨慢性肾脏病女性常见的月经紊乱、不孕和早绝经,认为下丘脑功能障碍可能参与异常生殖环境且可被肾移植或强化透析部分逆转;内源性雌二醇可能具有肾脏保护作用,而外源性雌二醇影响争议;选择性雌激素受体调节剂雷洛昔芬与骨折风险降低及肾脏保护相关;尚需大型前瞻性随机研究。
要点
- 慢性肾脏病女性月经紊乱、不孕和早绝经常见但常被低估。
- 下丘脑功能障碍而非卵巢功能障碍可能是异常生殖环境的原因,肾移植和强化透析可部分逆转。
- 内源性雌二醇可能对女性有肾脏保护作用,但外源性雌二醇对肾功能的影响更有争议。
核心结论
- 肾脏疾病女性的性激素异常可部分被肾移植和强化透析逆转,内源性雌二醇可能具有肾脏保护作用,外源性雌二醇对肾功能的影响更有争议,尚需大型前瞻性随机研究。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 慢性肾脏病女性中月经紊乱、不孕和早绝经常见但常被低估,下丘脑功能障碍而非卵巢功能障碍可能是异常生殖环境的原因。
- 肾移植和强化透析可至少部分逆转异常生殖环境。
- 内源性性激素尤其是雌二醇似乎对女性有肾脏保护作用,而外源性雌二醇(作为口服避孕药和绝经后激素治疗)对肾功能的影响更有争议。
- 终末期肾脏病(ESKD)女性接受绝经后激素治疗与生活质量、骨骼健康和心血管风险标志物改善相关,也与动静脉通路血栓风险增加相关。
- 选择性雌激素受体调节剂雷洛昔芬与肾脏疾病女性骨折风险降低及肾脏保护相关;年轻ESKD女性更可能死于感染或发生恶性肿瘤,提示雌激素的免疫调节作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 肾脏疾病女性中常见的早绝经是否导致心血管发病率和死亡率增加尚不清楚。
- 初步研究提示操纵性激素环境可能有助于降低该人群风险,但尚需大型前瞻性随机研究来探讨性激素在肾脏疾病女性中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Menstrual disorders, infertility and premature menopause are common but often underrecognized phenomena among women with chronic kidney disease. Hypothalamic, rather than ovarian dysfunction, may be the cause of the abnormal reproductive milieu, which can be at least partially reversed by kidney transplantation and increased intensity of hemodialysis. Endogenous sex hormones, and specifically estradiol, appear to be renoprotective in women, although the effects of exogenous estradiol (as an oral contraceptive and postmenopausal hormone therapy) on kidney function are more controversial. Treatment with postmenopausal hormone therapy in women with end-stage kidney disease (ESKD) has been associated with improved quality of life, bone health and markers of cardiovascular risk, as well as an increased risk of arteriovenous access thrombosis. The selective estrogen receptor modulator raloxifene has been associated with both a decreased fracture risk as well as renoprotection in women with kidney disease. Young women with ESKD are more likely to die from infection or develop malignancy, suggesting an immunomodulatory role of estrogen. Whether the premature menopause commonly observed in female patients with kidney disease results in increased cardiovascular morbidity and mortality is unknown, although preliminary studies have suggested a possible therapeutic role for manipulation of the sex hormone milieu to mitigate risk in this population. Large, prospective, randomized studies examining the role of sex hormones in women with kidney disease are required to address the question.
引用
- Ahmed SB, Ramesh S. Sex hormones in women with kidney disease. Nephrol Dial Transplant. 2016. PMID: 27190328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。